# A Study to Test if TEV-53275 is Effective in Relieving Asthma

> **NCT04847674** · PHASE2 · TERMINATED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 97 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** TEV-53275 Dose A
- **DRUG:** TEV-53275 Dose B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04847674
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-04
- **Primary completion:** 2022-04-28
- **Final completion:** 2022-04-28
- **Target enrollment:** 97 (ACTUAL)
- **Why stopped:** Stopped for strategic reasons
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04847674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04847674, "A Study to Test if TEV-53275 is Effective in Relieving Asthma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04847674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*